Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5761 to 5775 of 7677 results

  1. Home-based antipyretic use: The GDG recommends studies on home-based antipyretic use and parental perception of distress caused by fever. [2013]

    Recommendation ID NG143/05 Question Home-based antipyretic use: The GDG recommends studies on home-based antipyretic use and parental perception

    Research recommendation
    Published
    17 December 2021

  2. The effectiveness of pulsatile gonadotrophin-releasing hormone in women with clomifene citrate-resistant polycystic ovary syndrome is uncertain and is therefore not recommended outside a research context. [2004]

    Recommendation ID CG156/7 Question The effectiveness of pulsatile gonadotrophin-releasing hormone in women with clomifene citrate-resistant

    Research recommendation
    Published
    9 June 2015

  3. Further evidence to address uncertainties about the relative clinical and cost effectiveness of UroLift compared with Rezum, especially in the NHS, would be welcome. This should include: • exploring long-term clinical outcomes and reintervention rates after UroLift • assessing the suitability of UroLift for prostates larger than 80 ml and for those with an obstructive median lobe.

    Recommendation ID MTG58/1 Question Further evidence to address uncertainties about the relative clinical and cost effectiveness of UroLift

    Research recommendation
    Published
    10 August 2021

  4. Management by remote assessment: The GDG recommends that a UK study is undertaken to determine the validity of symptoms reported on remote assessment for children with fever.

    Recommendation ID NG143/02 Question Management by remote assessment: The GDG recommends that a UK study is undertaken to determine the

    Research recommendation
    Published
    17 December 2021

  5. The evidence for treating an acute migraine attack is adequate but, for treating subsequent attacks, is limited in quality and quantity. So, for treating acute migraine, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page . The evidence for preventing migraine is inadequate in quality. So, for preventing migraine, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG740/01 Question The evidence for treating an acute migraine attack is adequate but, for treating subsequent attacks

    Research recommendation
    Published
    7 November 2022

  6. The evidence on efficacy of nerve transfer to partially restore upper limb function in tetraplegia is limited in quantity. There are no major safety concerns. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research.

    Recommendation ID IPG610/1 Question The evidence on efficacy of nerve transfer to partially restore upper limb function in tetraplegia

    Research recommendation
    Published
    21 November 2018

  7. Diagnosis: The GDG recommends that a UK study of the performance characteristics and cost-effectiveness of procalcitonin versus C-reactive protein in identifying serious bacterial infection in children with fever without apparent source be carried out.

    Recommendation ID NG143/03 Question Diagnosis: The GDG recommends that a UK study of the performance characteristics and cost-effectiveness

    Research recommendation
    Published
    17 December 2021

  8. Management according to risk of serious illness: The GDG recommends that research is carried out on referral patterns between primary and secondary care for children with fever, so the health economic impact of this and future guidelines can be estimated.

    Recommendation ID NG143/07 Question Management according to risk of serious illness: The GDG recommends that research is carried out on

    Research recommendation
    Published
    17 December 2021

  9. The evidence on transvaginal laser therapy for stress urinary incontinence does not show any short-term safety concerns. Evidence on long-term safety andefficacy is inadequate in quality and quantity. Therefore, this procedure should only be used in the context of research. Find out what only in research means onthe NICE interventional procedures guidance page.

    Recommendation ID IPG696/1 Question The evidence on transvaginal laser therapy for stress urinary incontinence does not show any short-term

    Research recommendation
    Published
    10 August 2021

  10. The evidence on transvaginal laser therapy for urogenital atrophy does not show any short-term safety concerns. Evidence on long-term safety and efficacy is inadequate in quality and quantity. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG697/1 Question The evidence on transvaginal laser therapy for urogenital atrophy does not show any short-term safety

    Research recommendation
    Published
    10 August 2021

  11. Antipyretics: The GDG recommends that studies are conducted in primary care and secondary care to determine whether examination or re-examination after a dose of antipyretic medication is of benefit in differentiating children with serious illness from those with other conditions.

    Recommendation ID NG143/04 Question Antipyretics: The GDG recommends that studies are conducted in primary care and secondary care to determine

    Research recommendation
    Published
    17 December 2021

  12. The experience of consenting for organ donation:- Does a positive experience of approach and process of consent for families increase consent rates?

    Recommendation ID CG135/5 Question The experience of consenting for organ donation:- Does a positive experience of approach and process

    Research recommendation
    Published
    9 June 2015

  13. Symptoms and signs of serious illness: The Guideline Development Group (GDG) recommends a UK-based epidemiological study on the symptoms and signs of serious illness.

    Recommendation ID NG143/01 Question Symptoms and signs of serious illness: The Guideline Development Group (GDG) recommends a UK-based

    Research recommendation
    Published
    17 December 2021

  14. The health-related quality-of-life evidence of patients with perianal fistulas is also lacking, therefore further research is recommended. Any research should measure the effect of treatment using preference-based measures (such as use of the EQ-5D questionnaire).

    Recommendation ID TA556/2 Question The health-related quality-of-life evidence of patients with perianal fistulas is also lacking, therefore

    Research recommendation
    Published
    19 March 2019

  15. The physical health benefits of discontinuing antipsychotic medication:- What are the short- and long-term benefits to physical health of guided medication discontinuation and/or reduction in first episode psychosis and can this be achieved without major risks?

    Recommendation ID CG178/3 Question The physical health benefits of discontinuing antipsychotic medication:- What are the short- and long-term

    Research recommendation
    Published
    9 June 2015